GeminIQ Website Logo

Viewing BHC free

Subscribe for full history, 50+ metrics, screener, watchlist...

Bausch Health Companies Inc.

BHC

Companies in Pharmaceutical Preparations

Bausch Health Companies Inc. (BHC) — SEC Financial Statements & Analysis

Bausch Health Companies Inc. (BHC) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
1,2991,3091,3081,7271,1341,181719595733947760579
Restricted Cash Current
13163216232031282215209
Receivables Net Current
2,1912,3512,4172,2102,0722,1402,0942,1022,0481,9981,9481,743
Inventory Net
1,6011,6291,5981,6551,6131,5951,6551,6121,6361,5441,2721,240
Prepaid Expense And Other Assets Current
8748528949068908388528749571,0921,048890
Assets Current
5,9786,1576,2496,5145,7325,7745,3515,2115,3965,5965,0484,461
Property Plant And Equipment And Finance Lease Rig…
2,0952,0742,0261,9941,8821,7801,7891,7381,7131,7071,5841,599
Intangible Assets Net Excluding Goodwill
4,4044,6434,8305,0475,2975,5515,6525,9036,1836,4566,7285,299
Goodwill
9,80711,27111,28711,29811,15311,08711,17111,12711,16011,18311,18711,628
Deferred Income Tax Assets Net
1,8451,8432,0502,0251,9771,9682,1882,1872,1492,1012,1892,191
Other Assets Noncurrent
369378382388380363389329312307328325
Assets
24,49826,36626,82427,26626,42126,52326,54026,49526,91327,35027,06425,503
Liabilities
Liabilities Current
Accounts Payable Current
593600616627620589667579642719569515
Accrued Liabilities Current
3,0373,3443,5983,4693,3543,4893,3863,3383,2253,1333,1193,008
Long Term Debt Current
8892255798792822,674453452538450536444
Liabilities Current
4,5304,1804,7934,9754,2566,7524,5064,3694,4054,3024,2243,967
Long Term Debt Noncurrent
19,87520,59220,46320,85921,22818,94221,05421,20821,53621,93821,89420,108
Deferred Income Tax Liabilities Net
179147145144134128169170170163213215
Other Liabilities Noncurrent
763793843877761713805745751776721745
Liabilities
25,58025,98926,46827,11926,66126,84526,78226,72227,08727,43227,29925,232
Stockholders Equity
Common Stock Value
10,54210,51610,51510,51010,50810,49010,48910,48310,48010,42310,42010,412
Additional Paid In Capital Common Stock
295357275250220234201181164214190188
Retained Earnings Accumulated Deficit
-11,090-9,667-9,555-9,734-9,882-9,824-9,917-9,832-9,842-9,778-9,739-9,361
Accumulated Other Comprehensive Income Loss Net Of…
-1,806-1,760-1,800-1,790-2,029-2,179-1,947-2,007-1,917-1,881-2,051-1,902
Stockholders Equity
-2,059-554356-764-1,183-322-1,174-227-174-1,022-235271
Minority Interest
977931921911943957932948941940945934
Liabilities And Stockholders Equity
24,49826,36626,82427,26626,42126,52326,54026,49526,91327,35027,06425,503
Common Stock Shares Issued
373371370370370368368367367365365364
Shares Outstanding
373371370370370368368367367365365364

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026-4.37%-16.61%----------
2025-16.04%16.60%19.06%27.16%14.26%2.72%-8.77%4.08%5.60%-16.36%-5.56%-3.04%
2024-21.38%-15.95%-6.06%-3.77%31.64%33.77%-13.37%-18.80%-19.13%-0.42%-39.83%-36.07%
202338.20%22.07%62.82%-12.43%-12.65%-22.21%-5.59%1.50%11.04%-1.08%-5.81%-26.02%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Performance and Valuation Metrics

Metrics
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
1.32
1.47
1.30
1.31
1.35
0.86
1.19
1.19
1.22
1.30
1.20
1.12
Quick Ratio
0.77
0.88
0.78
0.79
0.76
0.49
0.63
0.62
0.64
0.69
0.65
0.59
Working Capital
1.45B
1.98B
1.46B
1.54B
1.48B
-978.00M
845.00M
842.00M
991.00M
1.29B
824.00M
494.00M
Leverage & Debt
Debt to Equity
-12.42
68.94
74.35
-35.50
-22.54
-83.37
-22.81
-117.72
-155.67
-334.54
-116.17
93.11
Interest Coverage TTM
0.35
1.13
1.23
1.08
1.13
1.11
0.95
0.74
0.78
0.73
0.29
0.45
Debt Ratio
1.04
0.99
0.99
0.99
1.01
1.01
1.01
1.01
1.01
1.00
1.01
0.99
Efficiency & Turnover
Asset Turnover TTM
0.41
0.39
0.38
0.37
0.36
0.36
0.35
0.35
0.34
0.33
0.32
0.31
Days Sales Outstanding TTM
73.88
79.84
82.09
79.83
77.27
78.46
77.86
76.26
76.05
78.94
78.77
74.05
Receivables Turnover TTM
4.94
4.57
4.45
4.57
4.72
4.65
4.69
4.79
4.80
4.62
4.63
4.93
Per Share Metrics
Diluted EPS TTM
-3.24
0.42
1.00
0.29
-0.11
-0.13
-0.53
-1.33
-1.27
-1.67
-2.66
-0.51
Free Cash Flow Per Share TTM
2.76
2.70
2.95
3.01
3.32
3.42
2.87
2.62
2.29
2.24
2.56
-1.71
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
71.64%
71.27%
71.31%
71.35%
71.39%
71.65%
71.36%
71.28%
71.28%
71.23%
71.17%
70.97%
Operating Profit Margin TTM
5.57%
17.66%
18.92%
16.19%
15.84%
16.06%
14.25%
11.37%
11.92%
11.00%
4.27%
7.13%
Net Profit Margin TTM
-11.47%
1.53%
3.74%
1.11%
-0.41%
-0.48%
-2.07%
-5.36%
-5.20%
-6.98%
-11.38%
-2.24%
Growth Metrics
Net Revenue Growth (1Y)
8.22%
6.66%
5.86%
7.13%
8.53%
9.91%
10.91%
10.20%
10.01%
7.79%
5.11%
1.93%
Net Income Growth (1Y)
2,920.00%
-441.30%
-291.33%
-122.11%
-91.42%
-92.47%
-79.84%
163.64%
32.39%
188.21%
-476.74%
-506.52%
EPS Growth (1Y)
2,894.08%
-438.64%
-289.83%
-121.93%
-91.48%
-92.53%
-80.00%
161.41%
31.12%
185.92%
-473.75%
-503.62%
Valuation Metrics
P/E TTM
-1.67
16.42
6.39
22.66
-59.78
-64.48
-15.34
-5.20
-8.35
-4.79
-3.09
-15.61
P/B
-0.98
6.84
6.73
-3.23
-2.02
-9.21
-2.56
-11.30
-22.37
-35.69
-12.78
10.77
P/S TTM
0.19
0.25
0.24
0.25
0.25
0.31
0.32
0.28
0.43
0.33
0.35
0.35
Market Cap
2.01B
2.58B
2.39B
2.47B
2.39B
2.97B
3.01B
2.56B
3.89B
2.93B
3.00B
2.92B
Enterprise Value
21.48B
22.07B
22.10B
22.48B
22.77B
23.40B
23.76B
23.60B
25.21B
24.37B
24.65B
22.89B
Calculated Values
Free Cash Flow TTM
1.03B
1.00B
1.10B
1.12B
1.23B
1.26B
1.06B
963.00M
839.00M
817.00M
934.00M
-623.00M
Net Debt
19.47B
19.49B
19.70B
20.01B
20.38B
20.44B
20.76B
21.04B
21.32B
21.44B
21.65B
19.97B
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-05-19Sale
Owner: Lee, Frank D.
Title: -
Shares: 24,456
Price/Share: $5.43
Value: $132,796.08
Shares Owned: 49,339
Relationship: Director
Ownership: Direct
2026-03-03Sale
Owner: Carson, Seana
Title: EVP, General Counsel
Shares: 4,420
Price/Share: $5.77
Value: $25,503.40
Shares Owned: 616,761
Relationship: Officer
Ownership: Direct
2026-02-27Sale
Owner: Carson, Seana
Title: EVP, General Counsel
Shares: 8,388
Price/Share: $5.95
Value: $49,908.60
Shares Owned: 809,258
Relationship: Officer
Ownership: Direct
2025-11-25Purchase
Owner: Paulson, & Co. Inc.
Title: -
Shares: 2,500,000
Price/Share: $6.25
Value: $15,625,000.00
Shares Owned: 73,255,869
Relationship: TenPercentOwner
Ownership: Indirect
2025-09-08Sale
Owner: Carson, Seana
Title: EVP, General Counsel
Shares: 13,370
Price/Share: $7.31
Value: $97,734.70
Shares Owned: 499,585
Relationship: Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
60.82%
Inst. Shares: 226,741,488
Shares Outstanding: 372,800,000
2025-12-31
62.69%
Inst. Shares: 232,531,890
Shares Outstanding: 370,900,000
2025-09-30
63.56%
Inst. Shares: 235,997,010
Shares Outstanding: 371,300,000
2025-06-30
68.46%
Inst. Shares: 253,917,480
Shares Outstanding: 370,900,000
2025-03-31
62.90%
Inst. Shares: 232,469,253
Shares Outstanding: 369,600,000

Research Faster.
Invest Smarter.

Bausch Health Companies Inc. (BHC) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 50+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.